Trial intelligence / Profile preview

Mesenchymal stem cell conditioned medium injection vs low level laser therapy for alopecia

IRCT20200127046282N27Phase 2Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Apr 2023
Modality
Stem Cell Therapies → Cell Therapies
Countries
1
01

Overview

Phase 2 trial of ACT-20-CM in alopecia areata (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Started Apr 2023; status: completed.

02

Drugs

ACT-20-CM
03

Conditions

alopecia areata

Beyond the preview

Go deeper on IRCT20200127046282N27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200127046282N27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call